moricizine
Sign in to saveAlso known as EN-313, Ethmozine®, ethyl 10-(beta-N-morpholinylpropionyl)phenothiazine-2-carbamate, ethyl 10-(3-morpholinopropionyl)phenothiazine-2-carbamate, Etmozin, [10-(3-Morpholin-4-yl-propionyl)-10H-phenothiazin-2-yl]-carbamic acid ethyl ester, Moracizine
Moracizine or moricizine, sold under the trade name Ethmozine, is an antiarrhythmic of class IC. It was used for the prophylaxis and treatment of serious and life-threatening ventricular arrhythmias, but was withdrawn in 2007 for commercial reasons.
In the Vinony graph
Within Vinony's link graph, moricizine is referenced by 355 other articles, and connects out to United States, World Health Organization and digital object identifier.
Vinony files it under 4-Morpholinyl compounds, Abandoned drugs and Antiarrhythmic agents.
Its subject is documented across 8 Wikipedia language editions.
Research
372 papers- Moricizine.The New England journal of medicine · 1992
- Pharmacokinetics of moricizine HCl.The American journal of cardiology · 1987
- Moricizine prevents atrial fibrillation by late sodium current inhibition in atrial myocytes.Journal of thoracic disease · 2022
- Clinical pharmacokinetics of moricizine.The American journal of cardiology · 1990
- Efficacy of moricizine in malignant ventricular arrhythmias.The American journal of cardiology · 1990
via PubMed
Wikidata facts
- Mass
- 427.156577
Show 4 more facts
- chemical formula
- C₂₂H₂₅N₃O₄S
- canonical SMILES
- CCOC(=O)NC1=CC2=C(C=C1)SC3=CC=CC=C3N2C(=O)CCN4CCOCC4
- World Health Organisation international non-proprietary name
- moracizine
- defined daily dose
- 0.75
Sources (3)
via Wikidata · CC0
~2 min read
Encyclopedic overview
4 sectionsContents
- Pharmacology
- Synthesis
- See also
- References
Moracizine or moricizine, sold under the trade name Ethmozine, is an antiarrhythmic of class IC. It was used for the prophylaxis and treatment of serious and life-threatening ventricular arrhythmias, but was withdrawn in 2007 for commercial reasons.
==Pharmacology== Moracizine, a phenothiazine derivative, undergoes extensive first-pass metabolism and is also extensively metabolized after it has entered the circulation. It may have pharmacologically active metabolites. A clinical study has shown that moracizine is slightly less effective than encainide or flecainide in suppressing ventricular premature depolarizations. Compared with disopyramide and quinidine, moracizine was equally or more effective in suppressing premature ventricular contractions, couplets, and nonsustained ventricular tachycardia.
Excerpted from Wikipedia’s “moricizine” article, available under the CC BY-SA 4.0 licence.